The Journal of Nutritional Biochemistry
Volume 21, Issue 9 , Pages 827-833 , September 2010

Antioxidant treatment protects diabetic rats from cardiac dysfunction by preserving contractile protein targets of oxidative stress

  • Aslihan Aydemir-Koksoy

      Affiliations

    • Department of Biophysics, Faculty of Medicine, Ankara University, Ankara, Turkey
    • ,
  • Ayca Bilginoglu

      Affiliations

    • Department of Biophysics, Faculty of Medicine, Ankara University, Ankara, Turkey
    • ,
  • Meltem Sariahmetoglu

      Affiliations

    • Departments of Pediatrics, Pharmacology and Biochemistry, University of Alberta, Edmonton, AB, Canada
    • ,
  • Richard Schulz

      Affiliations

    • Departments of Pediatrics, Pharmacology and Biochemistry, University of Alberta, Edmonton, AB, Canada
    • ,
  • Belma Turan

      Affiliations

    • Department of Biophysics, Faculty of Medicine, Ankara University, Ankara, Turkey
    • Corresponding Author InformationCorresponding author. Tel.: +90 312 3103010x386; fax: +90 312 3106370.

Received 20 February 2009 ,Revised 8 June 2009 ,Accepted 15 June 2009.

References 

  1. Fein FS, Kornstein LB, Strobeck JE, Capasso JM, Sonnenblick EH. Altered myocardial mechanics in diabetic rats. Circ Res. 1980;47:922–933
  2. Jourdon P, Feuvray D. Calcium and potassium currents in ventricular myocytes isolated from diabetic rats. J Physiol. 1993;470:411–429
  3. Xu Z, Patel KP, Lou MF, Rozanski GJ. Up-regulation of K+ channels in diabetic rat ventricular myocytes by insulin and glutathione. Cardiovasc Res. 2002;53:80–88
  4. Ayaz M, Ozdemir S, Ugur M, Vassort G, Turan B. Effects of selenium on altered mechanical and electrical cardiac activities of diabetic rat. Arch Biochem Biophys. 2004;426:83–90
  5. Ayaz M, Turan B. Selenium prevents diabetes-induced alterations in [Zn2+]i and metallothionein level of rat heart via restoration of cell redox cycle. Am J Physiol Heart Circ Physiol. 2006;290:H1071–H1080
  6. Cheung PY, Sawicki G, Wozniak M, Wang W, Radomski MW, Schulz R. Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation. 2000;101:1833–1839
  7. Sawicki G, Leon H, Sawicka J, Sariahmetoglu M, Schulze CJ, Scott PG, et al. Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2. Circulation. 2005;112:544–552
  8. Wang W, Sawicki G, Schulz R. Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2. Cardiovasc Res. 2002;53:165–174
  9. Viappiani S, Nicolescu AC, Holt A, Sawicki G, Crawford BD, Leon H, et al. Activation and modulation of 72 kDa matrix metalloproteinase-2 by peroxynitrite and glutathione. Biochem Pharmacol. 2009;77(5):826–834
  10. Siwik DA, Pagano PJ, Colucci WS. Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am J Physiol Cell Physiol. 2001;280:C53–C60
  11. Somerville RP, Oblander SA, Apte SS. Matrix metalloproteinases: old dogs with new tricks. Genome Biol. 2003;4:216
  12. Sung MM, Schulz CG, Wang W, Sawicki G, Bautista-Lopez NL, Schulz R. Matrix metalloproteinase-2 degrades the cytoskeletal protein alpha-actinin in peroxynitrite mediated myocardial injury. J Mol Cell Cardiol. 2007;43:429–436
  13. Ovechkin AV, Tyagi N, Rodriguez WE, Hayden MR, Moshal KS, Tyagi SC. Role of matrix metalloproteinase-9 in endothelial apoptosis in chronic heart failure in mice. J Appl Physiol. 2005;99:2398–2405
  14. McCawley LJ, Matrisian LM. Matrix metalloproteinases: they're not just for matrix anymore!. Curr Opin Cell Biol. 2001;13:534–540
  15. Moshal KS, Metreveli N, Tyagi SC. Mitochondrial matrix metalloproteinase activation and dysfunction in hyperhomocysteinemia. Curr Vasc Pharmacol. 2008;6:84–92
  16. Nelson KK, Melendez JA. Mitochondrial redox control of matrix metalloproteinases. Free Radic Biol Med. 2004;37:532–537
  17. Ryan ME, Usman A, Ramamurthy NS, Golub LM, Greenwald RA. Excessive matrix metalloproteinase activity in diabetes: inhibition by tetracycline analogues with zinc reactivity. Curr Med Chem. 2001;8:305–316
  18. Wang W, Schulze CJ, Suarez-Pinzon WL, Dyck JR, Sawicki G, Schulz R. Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury. Circulation. 2002;106:1543–1549
  19. Chow AK, Cena J, Schulz R. Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature. Br J Pharmacol. 2007;152:189–205
  20. Yaras N, Sariahmetoglu M, Bilginoglu A, Aydemir-Koksoy A, Onay-Besikci A, Turan B, et al. Protective action of doxycycline against diabetic cardiomyopathy in rats. Br J Pharmacol. 2008;155(8):1174–1184Epub 2008 Sep 22.
  21. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev. 2008;16(2):CD007176
  22. Morris CD, Carson S. Routine vitamin supplementation to prevent cardiovascular disease: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2003;139:56–70
  23. Flores-Mateo G, Navas-Acien A, Pastor-Barriuso R, Guallar E. Selenium and coronary heart disease: a meta-analysis. Am J Clin Nutr. 2006;84:762–773
  24. McNeill JH, Delgatty HL, Battell ML. Insulinlike effects of sodium selenate in streptozotocin-induced diabetic rats. Diabetes. 1991;40:1675–1678
  25. Berg EA, Wu JY, Campbell L, Kagey M, Stapleton SR. Insulin-like effects of vanadate and selenate on the expression of glucose-6-phosphate dehydrogenase and fatty acid synthase in diabetic rats. Biochimie. 1995;77:919–924
  26. Tavazzi L, Tognoni G, Franzosi MG, Latini R, Maggioni AP, Marchioli R, et al. GISSI-HF Investigators. Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure. Eur J Heart Fail. 2004;6(5):635–641
  27. Tuncay E, Seymen AA, Tanriverdi E, Yaras N, Tandogan B, Ulusu NN, et al. Gender related differential effects of Omega-3E treatment on diabetes-induced left ventricular dysfunction. Mol Cell Biochem. 2007;304:255–263
  28. Gao CQ, Sawicki G, Suarez-Pinzon WL, Csont T, Wozniak M, Ferdinandy P, et al. Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction. Cardiovasc Res. 2003;57:426–433
  29. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev. 2008;16(2):CD007176
  30. Morris CD, Carson S. Routine vitamin supplementation to prevent cardiovascular disease: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2003;139:56–70
  31. Flores-Mateo G, Navas-Acien A, Pastor-Barriuso R, Guallar E. Selenium and coronary heart disease: a meta-analysis. Am J Clin Nutr. 2006;84:762–773
  32. Alkhenizan AH, Al-Omran MA. The role of vitamin E in the prevention of coronary events and stroke. Meta-analysis of randomized controlled trials. Saudi Med J. 2004;25:1808–1814
  33. Schulz R. Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches. Annu Rev Pharmacol Toxicol. 2007;47:211–242
  34. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest. 1996;98:2572–2579
  35. Leon H, Baczko I, Sawicki G, Light PE, Schulz R. Inhibition of matrix metalloproteinases prevents peroxynitrite-induced contractile dysfunction in the isolated cardiac myocyte. Br J Pharmacol. 2008;153:676–683
  36. Yaras N, Bilginoglu A, Vassort G, Turan B. Restoration of diabetes-induced abnormal local Ca2+release in cardiomyocytes by angiotensin II receptor blockade. Am J Physiol Heart Circ Physiol. 2007;292:H912–H920
  37. Li S, Li X, Rozanski GJ. Regulation of glutathione in cardiac myocytes. J Mol Cell Cardiol. 2003;35:1145–1152
  38. Van Linthout S, Seeland U, Riad A, Eckhardt O, Hohl M, Dhayat N, et al Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy. Basic Res Cardiol. 2008;103:319–327
  39. Papp LV, Lu J, Holmgren A, Khanna KK. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal. 2007;9:775–806
  40. McLennan PL, Owen AJ, Slee EL, Theiss ML. Myocardial function, ischaemia and n-3 polyunsaturated fatty acids: a membrane basis. J Cardiovasc Med (Hagerstown). 2007;8(Suppl 1):S15–S18
  41. Pepe S, McLennan PL. (n-3) Long chain PUFA dose-dependently increase oxygen utilization efficiency and inhibit arrhythmias after saturated fat feeding in rats. J Nutr. 2007;137:2377–2383
  42. Jude S, Roger S, Martel E, Besson P, Richard S, Bougnoux P, et al. Dietary long-chain omega-3 fatty acids of marine origin: a comparison of their protective effects on coronary heart disease and breast cancers. Prog Biophys Mol Biol. 2006;90:299–325
  43. Pierce GN, Dhalla NS. Mechanisms of the defect in cardiac myofibrillar function during diabetes. Am J Physiol Endocrinol Metab. 1985;248:E170–E175
  44. Turan B, Desilets M, Acan LN, Hotomaroglu O, Vannier C, Vassort G. Oxidative effects of selenite on rat ventricular contractility and Ca movements. Cardiovasc Res. 1996;32:351–361
  45. Frears ER, Zhang Z, Blake DR, O'Connell JP, Winyard PG. Inactivation of tissue inhibitor of metalloproteinase-1 by peroxynitrite. FEBS Lett. 1996;381:21–24
  46. Schulze CJ, Wang W, Suarez-Pinzon WL, Sawicka J, Sawicki G, Schulz R. Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial [correction of myocardial] ischemia-reperfusion injury. Circulation. 2003;107:2487–2492
  47. Bloch-Damti A, Bashan N. Proposed mechanisms for the induction of insulin resistance by oxidative stress. Antioxid Redox Signal. 2005;7:1553–1567
  48. Ezaki O, Fukuda N, Itakura H. Role of two types of glucose transporters in enlarged adipocytes from aged obese rats. Diabetes. 1990;39:1543–1549
  49. Stapleton SR, Garlock GL, Foellmi-Adams L, Kletzien RF. Selenium: potent stimulator of tyrosyl phosphorylation and activator of MAP kinase. Biochim Biophys Acta. 1997;1355:259–269
  50. Bogdanov KY, Spurgeon HA, Vinogradova TM, Lakatta EG. Modulation of the transient outward current in adult rat ventricular myocytes by polyunsaturated fatty acids. Am J Physiol. 1998;274:H571–H579
  51. Rozanski GJ, Xu Z, Whitney RT, Murakami H, Zucker IH. Electrophysiology of rabbit ventricular myocytes following sustained rapid ventricular pacing. J Mol Cell Cardiol. 1997;29:721–732

PII: S0955-2863(09)00132-6

doi: 10.1016/j.jnutbio.2009.06.006

The Journal of Nutritional Biochemistry
Volume 21, Issue 9 , Pages 827-833 , September 2010

Article Tools

* Image Usage & Resolution